These are the main differences between the different types of GLP-1 agonists: Semaglutide (Ozempic, Wegovy) Strong anti-inflammatory potential Powerful metabolic benefits and weight loss Longer duration, but higher risk of GI and vestibular side effects Only works on immune cells receptors( not on adipose tissue directly) Tirzepatide (Mounjaro, Zepbound) Works on both GLP-1 and GIP receptors (targeting adipose tissue receptors) Strong anti-inflammatory and insulin-sensitivity effects Significant weight loss Higher likelihood of GI issues in some women Liraglutide (Saxenda) Daily injection Lowest weight loss and inflammation benefits Often gentler on the gut Poorer response for Lipedema in later stages The best choice often depends on: Your gut health Whether you struggle with dizziness or vestibular issues Your appetite levels Your sensitivity to medications Your nutrition status For Lipedema patients, Tirzepatide remains the best therapeutic choice to have a significant benefit on the adipose tissue
When Bifidobacterium populations surge, they consume more of the available resources, potentially crowding out other beneficial organisms
Alpha-synuclein oligomers interact with metal ions to induce oxidative stress and neuronal death in Parkinsons Disease
CRediT authorship contribution statement kos Gza Peth: Writing original draft, Conceptualization
Long-Term Maintenance Planning GLP-1 medications work as long as you take them, and most evidence supports long-term use for chronic weight management
other babies may sleep for 12 hours a day and their parents are miserable, because I guarantee that those hours are not occurring in a row
